GENE ONLINE|News &
Opinion
Blog

EMA Approval
Atara, Pierre Fabre’s EBV T-Cell Therapy Recommended For Approval In Europe
2022-10-17
EMA Begins Regulatory Review For Astellas’ Fezolinetant
2022-10-03
Merck’s Vaccine For Streptococcus Pneumoniae Lined Up for Another European Commission Approval
2022-09-16
Gilead’s Novel Capsid Inhibitor Treatment for HIV Gains First Approval from European Commission
2022-08-22
Oncopeptides’ Pepaxti Won EMA Approval for Multiple Myeloma
2022-08-19
Applications for Medicine Treating Crohn’s Disease Submitted to EMA and FDA
2022-07-29
BioMarin Wins First Gene Therapy Recommendation For Hemophilia A in Europe
2022-06-27
Bio-Europe Spring: 2022 Europe Ophthalmic Medication Market Skyrockets
2022-04-20
EMA Begins Review of BeiGene, Novartis’s PD-1 Antibody for Esophageal and Lung Cancer
2022-04-13
Good or Bad: The 4th Dose of mRNA COVID Vaccine
2022-04-12
EMA Accepts Application for AstraZeneca’s Anti-RSV Antibody Nirsevimab.
2022-02-21
Atara Biotherapeutics’ First-In-Class Allogeneic T-Cell Therapy Accepted for EMA Review
2021-12-02
GIVLAARI to Enter European Market Following EMA Approval
2020-03-04
LATEST
Neuro, Pain, and Cancer Top the List at JPM 2025 Healthcare Conference
2025-01-17
ZYN Nicotine Pouches Receive FDA Marketing Authorization
2025-01-17
Virginia’s Insurance Marketplace Extends Open Enrollment Deadline: A Detailed Report
2025-01-16
2025 Starts with a Jolt: Layoffs Hit the Life Sciences Industry Ahead of JPM
2025-01-16
Eli Lilly Steals the Spotlight at JPM 2025 with $2.5 Billion Power Move Acquisition
2025-01-16
Pre-JPM 2025: The Quiet Deals You May Have Missed Before the Big Show
2025-01-16
JPM 2025’s Billion Dollar Deal – GSK Bids Big in GI Cancer
2025-01-15
EVENT
2025-02-05
Precision Medicine World Conference 2025
Santa Clara, California
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
Scroll to Top